Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Clinical trial NCT00105235 · COMPLETED

Trial details

NCT number: NCT00105235
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Disease Liver Transplantation

Start date: 2005-06-01
Primary completion: 2007-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.